Cannabis Stocks On The Rise

By 2020, legal sales of cannabis on a global scale are expected to reach a goal of 230% growth to $31.3 billion. The projection of $23.4 billion is to be spent in the US alone. Compared to $9.5 billion seen in 2017 according to ArcView Market Research and BDS Analytics. There are key areas of varied investment that include:

  • Businesses which conduct their affairs in the direct production and distribution of cannabis products.
  • Companies that engage with supplies and hydroponic equipment.
  • Pharmaceutical and biotech companies that are working to produce treatments based on cannabinoids.
  • Companies that provide services in technology, real estate, consulting services and other aspects of the cannabis industry.

Cannabis Stocks – The Importance of Research

While investing in the burgeoning cannabis stocks the importance of reviewing regulations is a must. Even though Canada legalized cannabis in 2018 under US federal law it is still considered a class 1 drug and is in the same category as cocaine, heroin and LSD. This means cannabis cannot be researched for medicinal benefits. However, there are over 30 states that have legalized cannabis for recreational use. In 2018 alone Michigan, Missouri, Oklahoma, Utah voted in favour of cannabis legalization for medicinal and recreational purposes. Most recently in June of 2019 Illinois came on board with legalization. This has posed problems most significantly in the form of transportation. The Transportation Safety Administration (TSA) has had a difficult time in the transportation of cannabis products from legal states to non-legal states. This has resulted in confusion, resulting in a quagmire of red tape at times. However, investors shouldn’t worry as these problems will certainly rectify in the foreseeable future.

 Listed Marijuana Stocks  

In 2018 the New York Stock Exchange (NYSE) and Nasdaq saw their first cannabis listings. The Cronos Group made its trading debut that February. This May the Canopy Growth Corp. was the first to trade on the NYSE. Several companies still exist which deal with penny stocks are also traded in the “Over-the-Counter” (OTC) marketsBy looking at the following companies, it is apparent that each is diverse and articulate both the recreational and medicinal products. Both will add value to your investment portfolio. Here is are cannabis companies whose stocks are rising and well suited for long or short term investment
 
  • AURORA CANNABIS INC (ACB) – This Canadian company became larger last year by the acquisition of Medireleaf for $250 million. At the time this was the largest deal ever made.
  • CANOPY GROWTH CORP (CGC) – The world’s largest publicly traded cannabis company (CGC) markets both medicinal and recreational strains. The rapper Snoop Dogg is an investor in the companies popular stain “Tweed”. His promotion has helped this company to reach sales of nearly $60 million US in the 2019 fiscal year.
  • TERRA TECH CORP – This diversified company has operations with dispensing medicinal marijuana. This OTC listed company in the US. First quarter earnings for March 2018 were a healthy $6.8 million.

Biotech and Pharma 

Investments in the Biotech and Pharma are a great choice in this new branch of natural healing. New ground floor stock options will leave your broker drooling sound groundbreaking discoveries. Here are some top picks. 

  • Axim Biotechnologies (OTC: AXIM) 
  • AbbVie (ABBV) 
  • Cara Therapeutics (CARA) 
  • GW Pharmaceuticals 

Cannabis stocks are on the rise. With smart investments in diverse cannabis options stocks can be the right choice. Ancillary Business Investments or Cannabis Sin Stocks can help to formulate the big picture in the cannabis stock market. More discoveries are being made almost weekly in the medicinal cannabis field. This combined with legalization of recreational marijuana continues to see stocks climb.